| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Arbutus Biopharma Corp | Chief Financial Officer | Common Shares | 73,500 | $353,535 | $4.81 | 02 Feb 2026 | Direct |
| Arbutus Biopharma Corp | Chief Financial Officer | Stock Option (Right to Buy) | 188,400 | 02 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | 02 Feb 2026 | 2 | $0 | 4 | Chief Financial Officer | 02 Feb 2026, 20:21 |
| ABUS | Arbutus Biopharma Corp | 31 Mar 2025 | 1 | $0 | 4/A | Chief Financial Officer | 01 Apr 2025, 17:47 |
| ABUS | Arbutus Biopharma Corp | 28 Mar 2025 | 0 | $0 | 3 | Chief Financial Officer | 31 Mar 2025, 16:21 |